• By ICR Secretariat
  • Posted Wednesday, July 21, 2021

Biohaven CEO on migraine drug's fast launch, TikTok ads and battling big pharma


Migraine sufferers in the U.S. found some relief over the past few years as a handful of new treatments came to market. The additions include a group of injectable drugs that help prevent the painful headaches, as well as a pill, Ubrelvy, which was cleared in late 2019 to alleviate migraines after they start.